1-6 of 6
Yingmin Liang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5167.
https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167
Published: 2017
Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xuenong Ouyang, Xiaolin Li, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5213.
https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213
Published: 2017
Journal Articles

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2017) 130 (Supplement 1): 5208.
https://doi.org/10.1182/blood.V130.Suppl_1.5208.5208
Published: 2017
Journal Articles

A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, MD, Jianqiu Wu, MD, Yongping Song, Liping Su, Mingzhi Zhang, MD, Wei Li, Yu Hu, Xiaohong Zhang, MD, Yuhuan Gao, Ru Feng, MD, Wei Wang, MD, Zuoxing Niu, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changing Wu, Weijing Zhang, MD, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, Zimin Sun, PharmD, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2014) 124 (21): 5475.
https://doi.org/10.1182/blood.V124.21.5475.5475
Published: 2014
Journal Articles

A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy,

Xiaojun Huang, Fengrong Wang, Yuhong Chen, MD, PhD, Ting Liu, MD, Jianxiang Wang, MD, Jianda Hu, PhD, Jie Jin, MD, Fangping Chen, Shujie Wang, MD, PhD, Zhixiang Shen, MD, PhD, Li Yu, Kang Yu, Yingmin Liang
Journal: Blood
Blood (2011) 118 (21): 3241.
https://doi.org/10.1182/blood.V118.21.3241.3241
Published: 2011
Journal Articles

A Multicenter, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Posaconazole Vs Fluconazole in the Prophylaxis of Invasive Fungal Infection in a Chinese Population

Shen Yang, MD, Xiaojun Huang, Jianxiang Wang, MD, Jie Jin, PhD, Jianda Hu, PhD, Kang Yu, Depei Wu, MD, Shujie Wang, MD, PhD, Li Yu, Xiequn Chen, Ting Liu, MD, Yingmin Liang, Chen Fangping, MD, Yan Li, MD, Zhixiang Shen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4916.
https://doi.org/10.1182/blood.V118.21.4916.4916
Published: 2011